Literature DB >> 7647362

Bio-affinity characterization mass spectrometry.

J E Bruce1, G A Anderson, R Chen, X Cheng, D C Gale, S A Hofstadler, B L Schwartz, R D Smith.   

Abstract

A new approach, bio-affinity characterization mass spectrometry (BACMS), aimed at providing a more rapid, sensitive and potentially more flexible alternative to techniques presently employed for the characterization of noncovalent interactions in mixtures, such as would be encountered in combinatorial chemistry, in presented. BACMS avoids some of the difficulties and potential artifacts associated with affinity chromatography since the noncovalent associations occur in solution; thus, BACMS avoids the requirement of solid support media and the development of non-interfering linker species. This paper describes the conceptual basis for the methodology and its potential use in applications which include the screening of high affinity ligands in support of new drug development. BACMS exploits new Fourier-transform ion cyclotron resonance (FTICR) mass spectrometry technologies which, when coupled to electrospray ionization (ESI), allow the investigation of specific noncovalent complexes formed in solution. BACMS utilizes the well-known attributes of FTICR, such as the high resolution mass analysis and (MS)n (n > or = 2) capabilities; however, it is even more directly a result of recently developed techniques involving quadrupolar excitation, such as selected-ion accumulation. These tools are demonstrated and the results illustrate the extraordinary sensitivity achievable (solution concentration of 1 x 10-9 M without the use of separations prior to ESI). Thus, the new capabilities demonstrated here, in conjunction with ESI, will be useful for the investigation of very low relative concentration noncovalent association directly from solution, and promote a faster alternative for combinatorial mixture screening and analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647362     DOI: 10.1002/rcm.1290090805

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  6 in total

1.  Investigation of the noncovalent interactions between anti-amyloid agents and amyloid beta peptides by ESI-MS.

Authors:  Eric Martineau; Janna M de Guzman; Lioudmila Rodionova; Xianqi Kong; Paul M Mayer; Ahmed M Aman
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-31       Impact factor: 3.109

Review 2.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Guanbo Wang; Burcu Baykal; Shunhai Wang
Journal:  Biotechnol Adv       Date:  2011-05-17       Impact factor: 14.227

Review 3.  Advanced mass spectrometry-based methods for the analysis of conformational integrity of biopharmaceutical products.

Authors:  Cedric E Bobst; Igor A Kaltashov
Journal:  Curr Pharm Biotechnol       Date:  2011-10       Impact factor: 2.837

4.  Determinants of aminoglycoside-binding specificity for rRNA by using mass spectrometry.

Authors:  R H Griffey; S A Hofstadler; K A Sannes-Lowery; D J Ecker; S T Crooke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

5.  The influence of electrostatic interactions on the detection of heme-globin complexes in ESI-MS.

Authors:  A Schmidt; M Karas
Journal:  J Am Soc Mass Spectrom       Date:  2001-10       Impact factor: 3.109

Review 6.  Affinity selection-mass spectrometry in the discovery of anti-SARS-CoV-2 compounds.

Authors:  Richard B van Breemen; Ruth N Muchiri
Journal:  Mass Spectrom Rev       Date:  2022-08-05       Impact factor: 9.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.